Episode Details
Back to Episodes
229: Nobels for science, biotech dealmaking, & a friendly FTC
Published 4 years ago
Description
The newest Nobel laureates got their phone calls from Stockholm this week, and STAT science writer Megan Molteni joins us to explain their prize-winning work in medicine and chemistry. We also discuss the latest news in the life sciences, including the state of biotech dealmaking and the evolution of Amylyx Pharmaceuticals.